Page last updated: 2024-11-07

androstan-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Androstan-3-one, also known as 5α-androstan-3-one, is a naturally occurring steroid hormone found in various animal species. It is a key intermediate in the biosynthesis of testosterone and other androgens. Studies have shown that androstan-3-one exhibits a range of biological activities, including potential neuroprotective effects and anti-inflammatory properties. It is also a potent agonist of the GABA-A receptor, suggesting its involvement in regulating neuronal activity. The synthesis of androstan-3-one typically involves the reduction of testosterone using various reagents and catalysts. The importance of studying this compound lies in its potential therapeutic applications, especially in the treatment of neurodegenerative diseases and other conditions. Research continues to explore its role in the nervous system and its potential for pharmaceutical development.'

Cross-References

ID SourceID
PubMed CID102028
SCHEMBL ID1962644
MeSH IDM0114847

Synonyms (22)

Synonym
1224-95-9
androstan-3-one, (5.alpha.)-
5.alpha.-androstan-3-one
nsc-50893
nsc50893
androstan-3-one
(5s,8s,9s,10s,13s,14s)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
5-alpha-androstan-3-one
5alpha-androstan-3-one
androstan-3-one, (5alpha)-
unii-1mts8qn3ok
1mts8qn3ok ,
nsc 50893
SCHEMBL1962644
bdbm217387
steroid scaffold, 12
5a-androstan-3-one
(5s,8s,10s,13s)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one
Q27252625
(5~{s},8~{s},9~{s},10~{s},13~{s},14~{s})-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
nq8 ,
(3as,3bs,5as,9as,9bs,11as)-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-7-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ghrelin O-acyltransferaseHomo sapiens (human)IC50 (µMol)400.00006.00007.50008.0000AID1802486
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
peptide hormone processingGhrelin O-acyltransferaseHomo sapiens (human)
peptidyl-serine octanoylationGhrelin O-acyltransferaseHomo sapiens (human)
lipid modificationGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
O-acyltransferase activityGhrelin O-acyltransferaseHomo sapiens (human)
acyltransferase activity, transferring groups other than amino-acyl groupsGhrelin O-acyltransferaseHomo sapiens (human)
serine O-acyltransferase activityGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
endoplasmic reticulumGhrelin O-acyltransferaseHomo sapiens (human)
endoplasmic reticulum membraneGhrelin O-acyltransferaseHomo sapiens (human)
endoplasmic reticulum membraneGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1802486GOAT Activity Assay from Article 10.1021/acs.biochem.6b01008: \\Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.\\2017Biochemistry, 02-21, Volume: 56, Issue:7
Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.47 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]